RICHARD LECURU: Open Payments
NPI 1265051148 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $171 |
| ABBVIE INC. | 9 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $121 |
| Vanda Pharmaceuticals Inc. | 3 | $89 |
| Alkermes, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, ARISTADA, ABILIFY ASIMTUFII, Auvelity, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
